Unilife (UNIFF) 8-K Unilife Annual General Meeting

Confidential-Unilife Corporation

Confidential-Unilife Corporation

November 13, 2014

Annual General Meeting

Fiscal Year 2014

Exhibit 99.2

Confidential-Unilife Corporation

Confidential-Unilife Corporation

November 13, 2014

This

presentation contains forward looking statements under the safe harbor provisions

of the US securities laws. These forward-looking statements are based on management’s

beliefs and assumptions and on information currently available to our management.

Our management believes that these forward-looking statements are reasonable as

and when made. However you should not place undue reliance on any such forward

looking

statements

as

these

are

subject

to

risks

and

uncertainties.

Please

refer

to

our

press releases and our SEC filings for more information regarding the use of forward

looking statements.

Cautionary Note Regarding Forward-Looking Statements

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Welcome.

Mr. Alan Shortall.

Chairman and CEO

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Introducing our Board of Directors

•

In Attendance

Jim Bosnjak OAM

Mary Kate Wold, J.D.

John Lund, CPA

William Galle

Deputy Chairman

Director since 2002

Chair of the

Compensation

Committee

Non-Executive

Director since 2010

Chair of Strategic

Partnerships

Committee

Non-Executive

Director since 2009

Chair of Audit

Committee

Non-Executive Director

since 2008

Chair of the Nominating

and Corporate

Governance Committee

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Introducing our Board of Directors

•

Apologies

Jeff Carter MApp. BFin

Non-Executive Director since

2006

Based in Australia

Confidential-Unilife Corporation

Agenda

1.

Confirmation of Quorum

2.

Resolutions

3.

Presentation from the CEO

4.

Questions

5.

Confirmation of Results

6.

Other Business

Resolutions

1.00

Election of Directors

1.01

Elect Slavko James Joseph Bosnjak

1.02

Elect Jeff Carter

1.03

Elect William Galle

1.04

Elect John Lund

1.05

Elect Mary Katherine Wold

1.06

Elect Alan Shortall

2.00

Ratification of Auditor

3.00

Advisory Vote on Executive Compensation

4.00

Ratify Placement of Securities (Cantor)

5.00

Amendment to 2009 Stock Incentive Plan

6.00

Equity Grant

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Confirmation of Quorum

•

Unilife’s quorum requirement is one-third of outstanding

shares being represented either in person or by proxy

•

At least 55.70% of the total outstanding shares entitled to

vote have been received and are represented by person

or proxy

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Business Update

•

Customer-centric

•

Market-leading         

product portfolio

•

High-caliber team

•

Deep technical

capabilities

•

Strong partners

•

Execution with speed

A Preferred Partner Serving Customer Needs

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Value

Capitalizing on Converging Market Needs

Patients

Pharmaceutical

companies

Healthcare

providers

Confidential-Unilife Corporation

Our Business Model

•

Business to business (attractive operating margins)

•

Multiple shots on goal per customer

•

Long-term supply agreements

•

Predictable, recurring revenue

•

New agreements provide incremental revenue and growth

Confidential-Unilife Corporation

Our Commercial Supply Agreements.

Our Commercial Pipeline

15 active

programs

A leading indicator of

the future supply

agreements

Confidential-Unilife Corporation

Confidential-Unilife Corporation

A strategic global alliance

Scaling up to Meet Accelerating Demand

Building Long-Term Shareholder Value

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Building Value. Maximizing Revenue.

•

Continuing to invest in business opportunities that generate

substantial incremental revenue, and maximize value

•

Going cash flow positive is a question of when we choose to do so

•

Continuing to ramp up over the next two years and go

commercial with a growing number of injectable therapies

•

Targeting capacity for 400MM prefilled syringes and 10-15MM

wearable injectors plus scale-up for other products in our portfolio

•

Much of this demand is reserved and pre-sold

•

Alliance with Flextronics  supports  rapid scale-up to meet customer

demand,  reducing capital expenditure expenses and delivering a

favorable and meaningful cash flow benefit on our cash flows.

•

We will continue to invest in business opportunities that will

maximize shareholder value.

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Annual General Meeting of Stockholders

November 14, 2014

Consider and Vote for Matters set forth in Proxy Statement

Confidential-Unilife Corporation

Election of Directors

Item 1.

Confidential-Unilife Corporation

For

Withheld

Item 1.1   Jim Bosnjak

41,718,199

96.4%

1,559,173

3.6%

Item 1.2   Jeff Carter

40,696,315

94.04%

2,581,057

5.96%

Item 1.3   William Galle

41,879,595

96.77%

1,397,777

3.23%

Item 1.4   John Lund

42,342,898

97.84%

934,474

2.16%

Item 1.5   Mary Kate Wold

42,603,519

98.44%

673,853

1.56%

Item 1.6   Alan Shortall

40,896,391

94.50%

2,380,981

5.50%

Election of Directors

Item 1.

Confidential-Unilife Corporation

Item 2.

Ratification of the appointment of KPMG LLP as

the Corporation’s independent registered public

accounting firm for Fiscal Year 2015

Confidential-Unilife Corporation

Item 2.

Ratification of the appointment of KPMG LLP as

the Corporation’s independent registered public

accounting firm for Fiscal Year 2015

For

Against

Abstain

Item 2.

60,485,400 (99.48%)

210,006 (0.35%)

100,479 (0.17%)

Confidential-Unilife Corporation

To consider and act on an advisory vote regarding

the approval and  compensation paid to certain

executive officers

Item 3.

Confidential-Unilife Corporation

To consider and act on an advisory vote regarding

the approval and  compensation paid to certain

executive officers

For

Against

Abstain

Item 2.

34,117,944 (78.84%)

8,356,877 (19.31%)

802,551 (1.85%)

Item 3.

Confidential-Unilife Corporation

Item 4.

To ratify the issuance and sale of 7,308,800 shares of

common stock under the controlled equity offering

sales agreement entered into with Cantor Fitzgerald.

Confidential-Unilife Corporation

Item 4.

To ratify the issuance and sale of 7,308,800 shares of

common stock under the controlled equity offering

sales agreement entered into with Cantor Fitzgerald.

For

Against

Abstain

Item 4.

40,868,342 (94.44%)

1,909,643 (4.41%)

499,387 (1.15%)

Confidential-Unilife Corporation

Item 5.

To approve the issue and transfer of securities under

the 2009 Stock Incentive Plan and approval of the

2009 Stock Incentive Plan as amended.

Confidential-Unilife Corporation

Item 5.

To approve the issue and transfer of securities under

the 2009 Stock Incentive Plan and approval of the

2009 Stock Incentive Plan as amended.

For

Against

Abstain

Item 5.

34,584,320 (79.92%)

8,289,250 (19.15%)

403,802 (0.93%)

Confidential-Unilife Corporation

Item 6.

To ratify the issue of up to 4,000,000 shares of

restricted stock to Alan Shortall.

Confidential-Unilife Corporation

Item 6.

To ratify the issue of up to 4,000,000 shares of

restricted stock to Alan Shortall.

For

Against

Abstain

Item 6.

32,693,354 (75.54%)

10,027,717 (23.17%)

556,301 (1.29%)

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Final Comments

Confidential-Unilife Corporation

Confidential-Unilife Corporation

Close of Meeting